Trial Profile
Intraperitoneal Low Molecular Weight Heparin in Peritoneal Dialysis
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 26 May 2015
Price :
$35
*
At a glance
- Drugs Tinzaparin sodium (Primary)
- Indications Thrombosis
- Focus Adverse reactions
- Acronyms MesoHep-II
- 26 May 2015 New trial record